Related Experiment Videos
Gangliosides in human fetal brain.
L Svennerholm1, B M Rynmark, G Vilbergsson
1Department of Psychiatry and Neurochemistry, University of Göteborg, Sweden.
Journal of Neurochemistry
|May 1, 1991
Summary
During human fetal brain development, ganglioside concentration remained stable. Key ganglioside patterns shifted, with a decrease in ganglio b series and increases in GD1a and GM1, reflecting neurodevelopmental changes.
Area of Science:
- Neuroscience
- Developmental Biology
- Biochemistry
Background:
- Gangliosides are crucial glycosphingolipids involved in neuronal development and function.
- Human fetal brain development involves rapid neuroblast proliferation and migration from gestational week 10 to 22.
Purpose of the Study:
- To analyze the changes in ganglioside concentration and composition during early human fetal brain development (gestational weeks 10-22).
- To understand the dynamic shifts in specific ganglioside types during critical neurodevelopmental periods.
Main Methods:
- Analysis of ganglioside concentration and composition in 42 human fetal brains.
- Quantification of ganglioside sialic acid and identification of major ganglioside species (GT1b, GD1b, GD3, GQ1b, GD1a, GM1, 3'-isoLM1, 3'-LM1, 3',8'-LD1).
Main Results:
- Ganglioside concentration remained constant (approx. 1 μmol/g fresh weight) throughout the studied period.
- The ganglio b series, initially dominant (GT1b, GD1b), decreased, while GD1a and GM1 showed significant increases.
- Specific gangliosides like 3'-isoLM1 rapidly declined, contrasting with the slower decrease in neolacto series gangliosides.
Conclusions:
- Ganglioside composition undergoes significant dynamic changes during early human fetal brain development.
- These shifts in ganglioside patterns are associated with neuroblast proliferation, migration, and neuronal maturation.
- The observed changes suggest a role for specific gangliosides in regulating critical stages of brain development.